2Boulton AJ. The diabetic foot: a global view[J]. Diabetes Metab Res Rev ,2000,16( Suppl 1 ) :S2 - S5.
3Zucchi P, Ferrari P, Spina ML. Diabetic foot: from diagnosis to ther- apy [ J ]. Gltal Nefro1,2005,22 ( Suppl 31 ) : S20 - S22.
4Ziegler-Graham K, MacKenzie EJ, Ephraim PL, et al. Estimating the prevalence of limb loss in the United States : 2005 to 2050 [ J ]. Arch PhysMed Rehabil, 2008, 89 (3) : 422 - 429.
5Morag E, Pammer S, Boulton A, et al. Structural and functional as- pects of the diabetic foot [ J ]. Clin Biomcch ( Bristol, Avon), 1997,12(3) :S9 - S10.
6Berceli SA, Brown JE, Irwin PB, et al. Clinical outcomes after closed, staged, and open fore footamputations [ J ]. Vase Surg, 2006, 44(2) :347 -351.
7Marks RM, Long JT, Exten EL. Gait abnormality following amputation in diabetic patients[ J]. Foot Ankle Clin, 2010, 15 (3) : 501 - 507.
8Baur MD, Zupan TL, Gates KH, et al. Blood flow in the common femoral artery. Evaluation in a vascular laboratory[ J]. Am J Sury, 1983,145 : 585.
9Apelqvist J, Larsson J. What is tile most effective way to reduce in- cidence of amputation in the diabetic foot? [ J ]. Diabetes Metab Res Rev, 2000, 16(Suppll) : S75 -S83.
10Steffcns JC,Schlifer FK ,Oberseheid B,et al. Bolus-chasing contrast- enhanced 3D MRA of the lower extremity. Comparison with intraarte- fial DSA[ J]. Acta Radiol, 2003, 44(2) :185 -192.
